Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.
Also called NCT01191450
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 246 participants
- Sponsor
- Registry
-
NCT01191450
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT01191450. Randomized; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2025-06-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
- Acronym
- CARD
- Condition
- Arterial Hypertension
- Intervention (Drug)
- Chlorthalidone 25 mg + amiloride hydrochloride 5 mg
- Intervention (Drug)
- Higroton® Laboratório Novartis
- Lead sponsor
- Eurofarma Laboratorios S.A.
Record details
- Record id
cardio:ct-nct01191450- Content hash
29432e161158868af516cc64771f4cf38149e747c7754822027b068274e6fe88